These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 24795224)

  • 1. Integrated package approach in delivering interventions during immunisation campaigns in a complex environment in Papua New Guinea: a case study.
    Vince JD; Datta SS; Toikilik S; Lagani W
    Vaccine; 2014 Aug; 32(36):4614-9. PubMed ID: 24795224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Updating the evidence base on the operational costs of supplementary immunization activities for current and future accelerated disease control, elimination and eradication efforts.
    Gandhi G; Lydon P
    BMC Public Health; 2014 Jan; 14():67. PubMed ID: 24450832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strengthening routine immunization in Papua New Guinea: a cross-sectional provincial assessment of front-line services.
    Morgan CJ; Saweri OPM; Larme N; Peach E; Melepia P; Au L; Scoullar MJL; Reza MS; Vallely LM; McPake BI; Beeson JG
    BMC Public Health; 2020 Jan; 20(1):100. PubMed ID: 31973691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving immunisation: coverage in a province in Papua New Guinea.
    van Zwanenberg TD; Hull C
    Br Med J (Clin Res Ed); 1988 Jun; 296(6637):1654-6. PubMed ID: 3135060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Yellow fever control in Cameroon: where are we now and where are we going?
    Wiysonge CS; Nomo E; Mawo J; Ofal J; Mimbouga J; Ticha J; Ndumbe PM
    BMC Med; 2008 Feb; 6():3. PubMed ID: 18261201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of a catch-up programme to improve routine immunization in 13 provinces of Papua New Guinea, 2020-2022.
    Mekonnen DA; Bauri M; Pogo M; Shang M; Bettels D; Kabir SH; Edward W; Sibauk B; Dalton M; Miller G; Amarasinghe A; Takashima Y; Luo D; Huseynova S
    Western Pac Surveill Response J; 2023; 14(4):1-6. PubMed ID: 38230256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the impact of polio supplementary immunisation activities on routine immunisation and health systems: a systematic review.
    Vassallo A; Dunbar K; Ajuwon B; Lowbridge C; Kirk M; King C; Sheel M
    BMJ Glob Health; 2021 Nov; 6(11):. PubMed ID: 34776411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health and immunisation services for the urban poor in selected countries of Asia.
    Grundy J; Wang X; Hirabayashi KC; Duncan R; Bersonda D; Eltayeb AO; Mindra G; Nandy R
    Infect Dis Poverty; 2019 Apr; 8(1):26. PubMed ID: 30999956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Impact of Conflict on Immunisation Coverage in 16 Countries.
    Grundy J; Biggs BA
    Int J Health Policy Manag; 2019 Apr; 8(4):211-221. PubMed ID: 31050966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cost-effectiveness of supplementary immunization activities for measles: a stochastic model for Uganda.
    Bishai D; Johns B; Nair D; Nabyonga-Orem J; Fiona-Makmot B; Simons E; Dabbagh A
    J Infect Dis; 2011 Jul; 204 Suppl 1(Suppl 1):S107-15. PubMed ID: 21666151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Distributional Impact of Routine Immunization and Supplementary Immunization Activities in Delivery of Measles Vaccine in Low- and Middle-Income Countries.
    Portnoy A; Jit M; Helleringer S; Verguet S
    Value Health; 2020 Jul; 23(7):891-897. PubMed ID: 32762991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-benefit analyses of supplementary measles immunisation in the highly immunized population of New Zealand.
    Hayman DTS; Marshall JC; French NP; Carpenter TE; Roberts MG; Kiedrzynski T
    Vaccine; 2017 Sep; 35(37):4913-4922. PubMed ID: 28802754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the cost-effectiveness of different measles vaccination strategies for children in the Democratic Republic of Congo.
    Doshi RH; Eckhoff P; Cheng A; Hoff NA; Mukadi P; Shidi C; Gerber S; Wemakoy EO; Muyembe-Tafum JJ; Kominski GF; Rimoin AW
    Vaccine; 2017 Oct; 35(45):6187-6194. PubMed ID: 28966000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. System within systems: challenges and opportunities for the Expanded Programme on Immunisation in Pakistan.
    Haq Z; Shaikh BT; Tran N; Hafeez A; Ghaffar A
    Health Res Policy Syst; 2019 May; 17(1):51. PubMed ID: 31101060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of frequency and targeting of measles supplemental immunization activities in Nigeria: A cost-effectiveness analysis.
    Zimmermann M; Frey K; Hagedorn B; Oteri AJ; Yahya A; Hamisu M; Mogekwu F; Shuaib F; McCarthy KA; Chabot-Couture G
    Vaccine; 2019 Sep; 37(41):6039-6047. PubMed ID: 31471147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlling measles using supplemental immunization activities: a mathematical model to inform optimal policy.
    Verguet S; Johri M; Morris SK; Gauvreau CL; Jha P; Jit M
    Vaccine; 2015 Mar; 33(10):1291-6. PubMed ID: 25541214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of measles supplementary immunization activities on reaching children missed by routine programs.
    Portnoy A; Jit M; Helleringer S; Verguet S
    Vaccine; 2018 Jan; 36(1):170-178. PubMed ID: 29174680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of evidence updates on key determinants of measles vaccination impact: a DynaMICE modelling study in ten high-burden countries.
    Fu H; Abbas K; Klepac P; van Zandvoort K; Tanvir H; Portnoy A; Jit M
    BMC Med; 2021 Nov; 19(1):281. PubMed ID: 34784922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strengthening vaccination policies in Latin America: an evidence-based approach.
    Tapia-Conyer R; Betancourt-Cravioto M; Saucedo-Martínez R; Motta-Murguía L; Gallardo-Rincón H
    Vaccine; 2013 Aug; 31(37):3826-33. PubMed ID: 23357196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New pneumococcal conjugate vaccine introductions in four sub-Saharan African countries: a cross-country analysis of health systems' impacts.
    Torres-Rueda S; Burchett HE; Griffiths UK; Ongolo-Zogo P; Edengue JM; Kitaw Y; Molla M; Gelmon L; Onyango-Ouma W; Konate M; Mounier-Jack S
    Afr Health Sci; 2015 Sep; 15(3):868-77. PubMed ID: 26957976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.